U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848516) titled 'Change in Fat Fraction Quantification Before and After Treatment in Bone Metastases' on Sept. 16.

Brief Summary: Bone metastases are a common and serious complication of cancer. Treatment response is currently judged mainly by delayed changes on CT scans or X-rays, a process that can take months and sometimes produces misleading results. The study investigates whether a specialized, radiation-free MRI technique called Dixon imaging can detect early signs of treatment response by measuring fat content within bone metastases before and after chemotherapy or radiotherapy. As tumor tissue within a bone lesion responds to treatment, the l...